Operational Strategies for Late Phase
Fundamentally different from registration trials, post-marketing research offers new opportunities for flexibility, agility and creativity. Learn how we’re streamlining late phase clinical studies for time- and cost-efficiencies.
Monitoring for Quality: Risk-Based Clinical Monitoring
Scott Cooley, Executive Director of Phase IIIB/IV Product Management
